Loading clinical trials...
Loading clinical trials...
Somatic mutations in the MAP (mitogen-activated protein) kinase pathway have been found in about 80% of papillary thyroid tumors (PTCs). The evaluation of the PTC mutational profile is crucial for the...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Istituto Auxologico Italiano
NCT06316895 · Papillary Thyroid Cancer
NCT07140757 · Low Risk, Papillary Thyroid Cancer, and more
NCT05024929 · Papillary Thyroid Cancer, Pediatric Cancer, and more
NCT04948437 · Thyroid Cancer, Papillary Thyroid Cancer, and more
NCT04354324 · Papillary Thyroid Cancer
Istituto Auxologico Italiano
Milan, MI
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions